论文部分内容阅读
资料来源:EMEA网站发布时间:2011.02.18欧洲药品管理局回顾了嗜眠发作与甲流疫苗Pandemrix因果关系没有建立的进一步资料,进一步研究结果等待着欧洲药品局产品医学委员会(CHMP)的审查。来自芬兰的进一步数据疑似儿童和青少年的嗜睡症与Pandemrix有关系。委员会得出结论:新证据添加了在芬兰、瑞典的病例报告,但仍不足够证明Pandemrix与发作性嗜睡症的因果关系。进一步的证明和研究结果正在等待芬兰的澄清意见。
Source: EMEA Posted: 2011.02.18 EMEA reviewed further information on the absence of a causal relationship between narcolepsy and pandemic vaccine Pandemrix. Further research awaits review by the European Medicines Agency’s Pharmaceutical Board of Medicines (CHMP). Further data from Finland Suspected narcolepsy in children and adolescents is related to Pandemrix. The committee concluded that the new evidence added case reports in Finland and Sweden but not enough evidence of the causal link between Pandemrix and narcolepsy. Further evidence and findings are pending Finnish clarification.